Boston Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $226M | Sell |
643,175
-81,618
| -11% | -$29.1M | 0.24% | 144 |
|
|
2025
Q4 | $237M | Buy |
724,793
+1,059
| +0.1% | +$336K | 0.25% | 148 |
|
|
2025
Q3 | $204M | Sell |
723,734
-24,652
| -3% | -$7.15M | 0.21% | 158 |
|
|
2025
Q2 | $209M | Sell |
748,386
-55,019
| -7% | -$15.6M | 0.23% | 147 |
|
|
2025
Q1 | $250M | Sell |
803,405
-1,458,208
| -64% | -$431M | 0.3% | 119 |
|
|
2024
Q4 | $590M | Sell |
2,261,613
-30,567
| -1% | -$9.07M | 0.72% | 35 |
|
|
2024
Q3 | $738M | Sell |
2,292,180
-2,230
| -0.1% | -$729K | 0.87% | 17 |
|
|
2024
Q2 | $718M | Buy |
2,294,410
+57,076
| +3% | +$16.8M | 0.89% | 13 |
|
|
2024
Q1 | $635M | Buy |
2,237,334
+481,214
| +27% | +$141M | 0.76% | 28 |
|
|
2023
Q4 | $507M | Sell |
1,756,120
-224,579
| -11% | -$61.2M | 0.67% | 36 |
|
|
2023
Q3 | $531M | Sell |
1,980,699
-26,420
| -1% | -$6.59M | 0.74% | 33 |
|
|
2023
Q2 | $447M | Buy |
2,007,119
+178,152
| +10% | +$41.3M | 0.6% | 54 |
|
|
2023
Q1 | $442M | Buy |
1,828,967
+868,298
| +90% | +$213M | 0.61% | 52 |
|
|
2022
Q4 | $252M | Sell |
960,669
-190,671
| -17% | -$51.1M | 0.34% | 104 |
|
|
2022
Q3 | $260M | Sell |
1,151,340
-29,919
| -3% | -$7.25M | 0.38% | 89 |
|
|
2022
Q2 | $287M | Buy |
1,181,259
+26,858
| +2% | +$6.58M | 0.4% | 85 |
|
|
2022
Q1 | $279M | Buy |
1,154,401
+19,366
| +2% | +$4.45M | 0.34% | 105 |
|
|
2021
Q4 | $255M | Buy |
1,135,035
+412,337
| +57% | +$87M | 0.31% | 115 |
|
|
2021
Q3 | $154M | Buy |
722,698
+29,760
| +4% | +$6.85M | 0.19% | 169 |
|
|
2021
Q2 | $169M | Sell |
692,938
-475,983
| -41% | -$117M | 0.22% | 158 |
|
|
2021
Q1 | $291M | Buy |
1,168,921
+196,342
| +20% | +$46.8M | 0.39% | 85 |
|
|
2020
Q4 | $224M | Buy |
972,579
+952,081
| +4,645% | +$220M | 0.35% | 89 |
|
|
2020
Q3 | $5.21M | Sell |
20,498
-1,213
| -6% | -$301K | 0.01% | 360 |
|
|
2020
Q2 | $5.12M | Buy |
21,711
+7,640
| +54% | +$1.74M | 0.01% | 361 |
|
|
2020
Q1 | $2.85M | Buy |
14,071
+1,764
| +14% | +$385K | 0.01% | 394 |
|
|
2019
Q4 | $2.97M | Buy |
12,307
+4,250
| +53% | +$937K | ﹤0.01% | 426 |
|
|
2019
Q3 | $1.56M | Sell |
8,057
-2,779
| -26% | -$533K | ﹤0.01% | 535 |
|
|
2019
Q2 | $2M | Buy |
10,836
+348
| +3% | +$62.3K | ﹤0.01% | 532 |
|
|
2019
Q1 | $1.99M | Hold |
10,488
| – | – | ﹤0.01% | 548 |
|
|
2018
Q4 | $2.04M | Sell |
10,488
-49
| -0.5% | -$9.56K | ﹤0.01% | 546 |
|
|
2018
Q3 | $2.18M | Buy |
10,537
+362
| +4% | +$71.3K | ﹤0.01% | 593 |
|
|
2018
Q2 | $1.88M | Buy |
10,175
+223
| +2% | +$39.4K | ﹤0.01% | 669 |
|
|
2018
Q1 | $1.7M | Buy |
9,952
+698
| +8% | +$128K | ﹤0.01% | 669 |
|
|
2017
Q4 | $1.61M | Sell |
9,254
-643
| -6% | -$114K | ﹤0.01% | 685 |
|
|
2017
Q3 | $1.84M | Sell |
9,897
-1,429
| -13% | -$253K | ﹤0.01% | 679 |
|
|
2017
Q2 | $1.95M | Sell |
11,326
-3,860
| -25% | -$628K | ﹤0.01% | 660 |
|
|
2017
Q1 | $2.49M | Buy |
15,186
+3,833
| +34% | +$637K | ﹤0.01% | 635 |
|
|
2016
Q4 | $1.66M | Sell |
11,353
-728,258
| -98% | -$110M | ﹤0.01% | 682 |
|
|
2016
Q3 | $123M | Sell |
739,611
-751,758
| -50% | -$127M | 0.17% | 160 |
|
|
2016
Q2 | $227M | Buy |
1,491,369
+35,489
| +2% | +$5.52M | 0.33% | 113 |
|
|
2016
Q1 | $218M | Buy |
1,455,880
+18,988
| +1% | +$2.82M | 0.32% | 111 |
|
|
2015
Q4 | $233M | Sell |
1,436,892
-9,973
| -0.7% | -$1.57M | 0.33% | 99 |
|
|
2015
Q3 | $200M | Sell |
1,446,865
-110,772
| -7% | -$17.5M | 0.31% | 109 |
|
|
2015
Q2 | $239M | Sell |
1,557,637
-304,666
| -16% | -$48.8M | 0.34% | 91 |
|
|
2015
Q1 | $298M | Buy |
1,862,303
+41,146
| +2% | +$6.48M | 0.44% | 67 |
|
|
2014
Q4 | $290M | Sell |
1,821,157
-1,230,655
| -40% | -$192M | 0.44% | 68 |
|
|
2014
Q3 | $429M | Sell |
3,051,812
-14,821
| -0.5% | -$1.94M | 0.7% | 38 |
|
|
2014
Q2 | $363M | Sell |
3,066,633
-1,904,332
| -38% | -$220M | 0.61% | 47 |
|
|
2014
Q1 | $613M | Sell |
4,970,965
-154,702
| -3% | -$18.8M | 1.12% | 16 |
|
|
2013
Q4 | $585M | Buy |
5,125,667
+13,425
| +0.3% | +$1.53M | 1.2% | 13 |
|
|
2013
Q3 | $572M | Sell |
5,112,242
-93,067
| -2% | -$10.1M | 1.38% | 12 |
|
|
2013
Q2 | $514M | Buy |
+5,205,309
| New | +$540M | 1.41% | 13 |
|
Other funds holding AMGN
VCM
VPM
Boston Partners's AMGN Position: Q1 2026 in Review
Boston Partners reduced its Amgen (AMGN) stake by 11% in Q1 2026, selling an estimated $29.1M and leaving 643,175 shares worth $226M. The position accounts for 0.24% of the portfolio, ranked #144.
Boston Partners first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $738M in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Boston Partners held 643,175 shares of Amgen worth $226M as of Q1 2026.
- Boston Partners sold 81,618 Amgen shares in Q1 2026, an estimated $29.1M.
- Amgen made up 0.24% of Boston Partners's portfolio in Q1 2026, its #144 holding.
- Boston Partners first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Boston Partners's Amgen position peaked at $738M in Q3 2024.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.